Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
A recent retrospective study involving a large sample size of 1,890,020 diabetic patients found that GLP-1RAs were associated with a significantly lower risk of hepatocellular carcinoma compared to insulin and other diabetic medications over a 5-year follow-up period (Wang et al., 2024a)
Unexpected adverse events should be reported to the FDA MedWatch program
Previous weight loss history Your track record matters
If you miss a dose, follow the guidance provided by your healthcare professional or clinical trial team
Ozempic alternatives GLP-1 alternatives Mounjaro and Zepbound (tirzepatide) Tirzepatide is the active ingredient in Mounjaro and Zepbound
Reaching HBV-DNA negativity is an important milestone in the treatment of chronic hepatitis B, as it is associated with reduced viral replication and liver inflammation
